APA

Bonnefous C., Payne J. E., Roppe J., Zhuang H., Chen X., Symons K. T., Nguyen P. M., Sablad M., Rozenkrants N., Zhang Y., Wang L., Severance D., Walsh J. P., Yazdani N., Shiau A. K., Noble S. A., Rix P., Rao T. S., Hassig C. A. & Smith N. D. (20090602). Discovery of inducible nitric oxide synthase (iNOS) inhibitor development candidate KD7332, part 1: Identification of a novel, potent, and selective series of quinolinone iNOS dimerization inhibitors that are orally active in rodent pain models. : Journal of medicinal chemistry.

Chicago

Bonnefous Céline, Payne Joseph E, Roppe Jeffrey, Zhuang Hui, Chen Xiaohong, Symons Kent T, Nguyen Phan M, Sablad Marciano, Rozenkrants Natasha, Zhang Yan, Wang Li, Severance Daniel, Walsh John P, Yazdani Nahid, Shiau Andrew K, Noble Stewart A, Rix Peter, Rao Tadimeti S, Hassig Christian A and Smith Nicholas D. 20090602. Discovery of inducible nitric oxide synthase (iNOS) inhibitor development candidate KD7332, part 1: Identification of a novel, potent, and selective series of quinolinone iNOS dimerization inhibitors that are orally active in rodent pain models. : Journal of medicinal chemistry.

Harvard

Bonnefous C., Payne J. E., Roppe J., Zhuang H., Chen X., Symons K. T., Nguyen P. M., Sablad M., Rozenkrants N., Zhang Y., Wang L., Severance D., Walsh J. P., Yazdani N., Shiau A. K., Noble S. A., Rix P., Rao T. S., Hassig C. A. and Smith N. D. (20090602). Discovery of inducible nitric oxide synthase (iNOS) inhibitor development candidate KD7332, part 1: Identification of a novel, potent, and selective series of quinolinone iNOS dimerization inhibitors that are orally active in rodent pain models. : Journal of medicinal chemistry.

MLA

Bonnefous Céline, Payne Joseph E, Roppe Jeffrey, Zhuang Hui, Chen Xiaohong, Symons Kent T, Nguyen Phan M, Sablad Marciano, Rozenkrants Natasha, Zhang Yan, Wang Li, Severance Daniel, Walsh John P, Yazdani Nahid, Shiau Andrew K, Noble Stewart A, Rix Peter, Rao Tadimeti S, Hassig Christian A and Smith Nicholas D. Discovery of inducible nitric oxide synthase (iNOS) inhibitor development candidate KD7332, part 1: Identification of a novel, potent, and selective series of quinolinone iNOS dimerization inhibitors that are orally active in rodent pain models. : Journal of medicinal chemistry. 20090602.